DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...

Investing.com -- DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), which now recommend using continuous glucose monitors ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...

The BNY Mellon Small/Mid Cap Growth Fund (Class A at NAV) returned 3.05% during the third quarter of 2024. Read more here.

AFib-treating cardiac ablation, surgical robotics, nitinol and diabetes treatment tech lead among this year’s top medtech ...

Mack Hansen, Bundee Aki, Finlay Bealham and Cian Prendergast have all been given this week off after the Autumn Nations ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

BlueFocus Communication Group Co. Ltd. is engaged in the provision of strategic public relations services. Its major services include brand marketing, products promotion, media relations, investor ...

Pre-Market: 8:00:41 a.m. EST ...